Purpose
The purpose of this meeting is to discuss NRC staff requests for additional information dated December 18, 2020 (ADAMS No. ML20352A225) related to the production of lutetium-177 (Lu-177), and the construction and operation of the proposed SHINE headquarters and therapeutics facilities.
Meeting Feedback
Meeting Dates and Times
01/12/21, 9AM - 10AM EST
Meeting Location
Teleconference
Contact
Jennifer Davis
(301) 415-3835
Nancy Martinez
(630) 829-9734
Participation Level
Category 1
NRC Participants
Office of Nuclear Material Safety and Safeguards
External Participants
SHINE Medical Technologies
Docket Numbers - Facility Names
05000608 - SHINE Medical Technologies, Inc.
Teleconference
Bridge Number: 3015762978
Passcode: 803406421
Comments
This public meeting will be conducted using Microsoft Teams. Interested members of the public may participate by either dialing the telephone number provided above or using the Microsoft Teams link.